Trade-Ideas LLC identified

Baxter International

(

BAX

) as an unusual social activity candidate. In addition to specific proprietary factors, Trade-Ideas identified Baxter International as such a stock due to the following factors:

  • BAX has 12x the normal benchmarked social activity for this time of the day compared to its average of 4.90 mentions/day.
  • BAX has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $217.5 million.

Identifying stocks with 'Unusual Social Activity' tends to be a valuable process for traders looking to capitalize on the 'talk of the town' stocks that are basking in far more attention from the StockTwits financial community than normal. Good press? Bad press? It ultimately doesn't matter if it's good or bad if you know how to trade around the sentiment. Certain hedge funds use such data for their proprietary algorithms and it is not uncommon to see shared social sentiment play itself out in a stock's price trend.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in BAX with the Ticky from Trade-Ideas. See the FREE profile for BAX NOW at Trade-Ideas

More details on BAX:

Baxter International Inc., develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. The stock currently has a dividend yield of 1.3%. BAX has a PE ratio of 11. Currently there is 1 analyst that rates Baxter International a buy, no analysts rate it a sell, and 11 rate it a hold.

TheStreet Recommends

The average volume for Baxter International has been 8.7 million shares per day over the past 30 days. Baxter International has a market cap of $19.3 billion and is part of the health care sector and health services industry. The stock has a beta of 0.56 and a short float of 2.7% with 2.30 days to cover. Shares are down 3.4% year-to-date as of the close of trading on Monday.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

TheStreetRatings.com

Analysis:

TheStreet Quant Ratings

rates Baxter International as a

buy

. The company's strengths can be seen in multiple areas, such as its solid stock price performance, attractive valuation levels, good cash flow from operations, expanding profit margins and largely solid financial position with reasonable debt levels by most measures. We feel its strengths outweigh the fact that the company has had somewhat weak growth in earnings per share.

Highlights from the ratings report include:

  • Compared to its closing price of one year ago, BAX's share price has jumped by 231.93%, exceeding the performance of the broader market during that same time frame. Regarding the stock's future course, although almost any stock can fall in a broad market decline, BAX should continue to move higher despite the fact that it has already enjoyed a very nice gain in the past year.
  • Net operating cash flow has increased to $696.00 million or 16.19% when compared to the same quarter last year. The firm also exceeded the industry average cash flow growth rate of -31.77%.
  • The gross profit margin for BAXTER INTERNATIONAL INC is rather high; currently it is at 55.90%. It has increased from the same quarter the previous year. Regardless of the strong results of the gross profit margin, the net profit margin of 8.52% trails the industry average.
  • Despite the current debt-to-equity ratio of 1.78, it is still below the industry average, suggesting that this level of debt is acceptable within the Health Care Equipment & Supplies industry. Despite the fact that BAX's debt-to-equity ratio is mixed in its results, the company's quick ratio of 1.51 is high and demonstrates strong liquidity.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.